Patents by Inventor Richard Welter

Richard Welter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9839627
    Abstract: Provided are novel methods comprising administering a therapeutically effective amount of (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane, in free or pharmaceutically acceptable salt form, to a patient in need thereof.
    Type: Grant
    Filed: December 9, 2014
    Date of Patent: December 12, 2017
    Assignee: NEUROVANCE, INC.
    Inventors: Anthony McKinney, Frank Gentile, Timothy Hsu, Franklin Bymaster, Walter Piskorski, Richard Welter
  • Publication number: 20160346249
    Abstract: The present invention relates to (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and pharmaceutically acceptable active salts, polymorphs, glycosylated derivatives, metabolites, solvates, hydrates, and/or prodrugs of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and their use alone or in combination with additional psychotherapeutic compositions in the treatment of conditions affected by monoamine neurotransmitters, including treatment of refractory individuals. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane compositions are metabolized by either or both MAO-A or cytochrome P450 enzymes and thus are effective in the treatment of individuals with cytochrome P450 polymorphisms or who are taking other medications that affect the cytochrome P450 pathway.
    Type: Application
    Filed: August 9, 2013
    Publication date: December 1, 2016
    Inventors: Anthony Alexander McKinney, Frank Bymaster, Richard Welter, Randall Marshall
  • Publication number: 20160303076
    Abstract: Provided are novel methods comprising administering a therapeutically effective amount of (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane, in free or pharmaceutically acceptable salt form, to a patient in need thereof.
    Type: Application
    Filed: December 9, 2014
    Publication date: October 20, 2016
    Applicant: Neurovance, Inc.
    Inventors: Anthony MCKINNEY, Frank GENTILE, Timothy HSU, Franklin BYMASTER, Walter PISKORSKI, Richard WELTER
  • Patent number: 8496788
    Abstract: A method and a device for producing and storing electrical energy using iron complexes, using an iron +III molecular complex as well as a photoreduced iron +II complex, both complexed chemically by a ligand of the benzoic hydrazide type.
    Type: Grant
    Filed: April 21, 2009
    Date of Patent: July 30, 2013
    Assignee: IS2 S.A.S.
    Inventor: Richard Welter
  • Publication number: 20110033741
    Abstract: A method and a device for producing and storing electrical energy using iron complexes, using an iron +III molecular complex as well as a photoreduced iron +II complex, both complexed chemically by a ligand of the benzoic hydrazide type.
    Type: Application
    Filed: April 21, 2009
    Publication date: February 10, 2011
    Applicant: IS2 S.A.S.
    Inventor: Richard Welter
  • Patent number: 7090816
    Abstract: A process for manufacturing ammonia from syngas with excess air for reforming and nitrogen removal with low pressure losses is disclosed. Auto-refrigeration for cooling the syngas for cryogenic hydrogen enrichment is provided by expansion of a hydrogen-lean waste fluid stream from a distillation column.
    Type: Grant
    Filed: July 17, 2003
    Date of Patent: August 15, 2006
    Assignee: Kellogg Brown & Root LLC
    Inventors: Avinash Malhotra, Tufail Ahmad, Bradley Richard Welter